REQUEST A DEMO
Total
USD $0.00
Search more companies

INTEGRAL VENTURE PARTNERS Kft. (Hungary)

Main Activities: Other Financial Investment Activities
Full name: INTEGRAL VENTURE PARTNERS Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Integral Venture Partners is a private equity and growth capital investment firm. The company focuses on investments in central and south-eastern Europe. The company has made strategic investments in companies such as LuminoChem, Breaktime, and Medima Health. Integral Venture Partners focuses on identifying growing branded consumer assets within the broader CEE region and has a team with over 100 years of combined investment experience.

Headquarters
Vaci ut 99-105. Balance Hall. ep. IV. emelet
Budapest; Budapest; Postal Code: 1139

Contact Details: Purchase the INTEGRAL VENTURE PARTNERS Kft. report to view the information.

Website: http://www.integralvp.com

Basic Information
Total Employees:
Purchase the INTEGRAL VENTURE PARTNERS Kft. report to view the information.
Outstanding Shares:
Purchase the INTEGRAL VENTURE PARTNERS Kft. report to view the information.
Registered Capital:
Purchase the INTEGRAL VENTURE PARTNERS Kft. report to view the information.
Financial Auditors:
Purchase the INTEGRAL VENTURE PARTNERS Kft. report to view the information.
Incorporation Date:
May 07, 2019
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after INTEGRAL VENTURE PARTNERS Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
-1.53%
Total operating revenue
-1.31%
Operating profit (EBIT)
-12.45%
EBITDA
-11.93%
Net Profit (Loss) for the Period
-20.67%
Total assets
19.49%
Total equity
26.63%
Operating Profit Margin (ROS)
-1.22%
Net Profit Margin
-2%
Return on Equity (ROE)
-12.54%
Quick Ratio
1.93%
Cash Ratio
0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?